IL1A ELISA Kit

Produktnummer ABIN6209919

Das Affe IL1A ELISA Kit (ABIN6209919) ist ein Colorimetric ELISA Kit zur Detektion von Affe IL1A.

Kurzübersicht für IL1A ELISA Kit (ABIN6209919)

Target: IL1A (Interleukin 1 alpha (IL1A))

Reaktivität: Affe

Nachweismethode: Colorimetric

Methodentyp: Sandwich ELISA

Detektionsbereich: 7.8 pg/mL - 500 pg/mL

Applikation: ELISA

Proben: Plasma, Serum

Produktdetails IL1A ELISA Kit

Untere Nachweisgrenze: 7.8 pg/mL

Analytische Methode: Quantitative

Sensitivität: < 2.5 pg/mL

Bestandteile: The kit components listed are for reference only. The product manual may differ slightly. The product should be used as stated on the product manual included and delivered together with the product.

• Pre-coated 96-Well Microplate
• Standard
• Standard Diluent Buffer
• Wash Buffer
• Detection Reagent A
• Detection Reagent B
• Diluent A
• Diluent B
• TMB Substrate
• Stop Solution
• Plate Sealer

Benötigtes Material:

• 37 °C incubator
• Multi and single channel pipettes and sterile pipette tips
• Squirt bottle or automated microplate washer
• 1.5 mL tubes
• Distilled water
• Absorbent filter papers
• 100 mL and 1 liter graduated cylinders
• Microplate reader (wavelength: 450 nm)
• ELISA Shaker

Anwendungsinformationen

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C

Informationen zur Lagerung: Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual.The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Haltbarkeit: 6 months

Details zu IL1A

Target: IL1A (Interleukin 1 alpha (IL1A))

Andere Bezeichnung: Interleukin 1 Alpha

UniProt: P79340

Pathways: NF-kappaB Signalweg, Autophagie, Cancer Immune Checkpoints